Price & volume screen · refreshed after the Sep 28, 2026 close

New highs

Stocks that closed at their highest level of the trailing year. A close above every other close in the trailing window. Stocks making new highs have no overhead supply from buyers waiting to break even, which is why many momentum approaches start here.

CriteriaClose ≥ every close in the trailing windowPrice ≥ $2Market cap ≥ $300M50 stocks
#CompanyPriceToday1M6MMkt cap
1ABBVABBVIEHealthcare$266.28+0.73%+3.1%+27.2%$470.55B
2TMOThermo Fisher ScientificTechnology$678.60+0.53%+7.6%+43.4%$250.91B
3WBDWarner Bros. Discovery, Inc. Series ACommunication Services$30.90+0.13%+7.0%+14.1%$77.47B
4AAgilent TechnologiesHealthcare$175.21+1.40%+11.1%+58.9%$49.40B
5WATWatersHealthcare$442.94+2.17%+5.1%+53.2%$43.52B
6BIIBBiogenHealthcare$228.69+0.48%+3.2%+24.4%$33.79B
7MTDMettler-Toledo InternationalHealthcare$1,545.26+2.22%+9.8%+25.4%$30.96B
8GMABGenmab A/S ADSUnclassified$35.36+0.11%+3.7%+36.9%$21.74B
9VTRSViatrisHealthcare$18.27+2.47%+8.2%+40.0%$20.98B
10TXG10x GenomicsHealthcare$88.50+3.26%+36.5%+354.3%$11.53B
11RGENRepligenHealthcare$194.09+2.33%+6.6%+76.3%$10.95B
12MSGSMadison Square Garden SportsCommunication Services$416.34+3.35%+5.8%+33.8%$10.03B
13AMRXAmneal PharmaceuticalsHealthcare$20.50+3.69%+13.8%+73.0%$7.14B
14GRALGRAILHealthcare$132.63+4.52%+60.8%+173.5%$5.92B
15KODKodiak SciencesHealthcare$89.92+177.96%+129.9%+143.0%$5.65B
16ABCLAbCellera BiologicsHealthcare$13.92+9.61%+12.3%+325.7%$4.51B
17BATRAAtlanta Braves Holdings, Inc. Series ACommunication Services$59.61+0.98%+6.9%+29.1%$3.83B
18BATRKAtlanta Braves Holdings, Inc. Series CCommunication Services$54.29+0.06%+6.8%+30.7%$3.48B
19CDNACareDxHealthcare$64.60+1.44%+23.4%+285.0%$3.34B
20ATKRAtkoreIndustrials$94.60+0.03%+1.0%+60.0%$3.19B
21IMAXImaxHealthcare$56.13+0.14%+8.1%+53.6%$3.08B
22AMCAMC ENTERTAINMENT HOLDINGSCommunication Services$3.29+11.90%+21.9%+247.0%$2.94B
23PRLBPROTO LABSMaterials$96.90+0.68%+21.0%+72.9%$2.32B
24CNXNPC ConnectionConsumer Discretionary$89.70+0.43%+11.3%+57.0%$2.26B
25BLFSBioLife SolutionsHealthcare$39.15+1.71%+5.2%+110.6%$1.92B
26DSGRDistribution Solutions GroupConsumer Discretionary$35.00+0.11%+0.5%+34.5%$1.62B
27GICGlobal IndustrialConsumer Discretionary$42.32+1.98%+6.8%+36.1%$1.61B
28CRCTCricutTechnology$6.33+3.09%+11.4%+67.0%$1.33B
29POCTInnovator U.S. Equity Power Buffer ETF - OctoberFund$47.79+0.02%+0.8%+12.6%$952.2M
30MGMistras GroupIndustrials$21.59+0.33%+12.2%+48.0%$687.9M
31EVACEQV Ventures Acquisition Corp. IIFinancials$10.32+0.10%+0.2%+2.5%$603.2M
32SGHTSight SciencesHealthcare$9.27+3.81%+10.2%+138.9%$510.7M
33PBYIPUMA BIOTECHNOLOGYHealthcare$9.82+0.51%+6.3%+61.5%$506.9M
34HBBHamilton Beach Brands HoldingConsumer Discretionary$37.60+0.91%+16.2%+113.2%$505.4M
35MTLSMaterialise NVUnclassified$8.58+1.78%+15.6%+78.8%$495.2M
36MASS908 DevicesHealthcare$11.66+1.92%+5.0%+101.7%$482.0M
37CIXComp X InternationalMaterials$38.91+2.94%+22.2%+68.0%$480.0M
38AGENAgenusHealthcare$9.43+10.42%+20.7%+178.2%$425.9M
39UUPInvesco DB US Dollar Index Bullish FundFinancials$28.70+0.28%+2.4%+3.1%$423.3M
40TWINTwin Disc, IncorporatedIndustrials$26.46+1.26%+13.3%+74.2%$384.7M
41RISRFolioBeyond Alternative Income and Interest Rate Hedge ETFFund$36.94+0.22%+0.5%+1.4%$382.0M
42GIWGigCapital8Financials$10.17+0.10%+0.3%+2.0%$370.9M
43TACHTitan AcquisitionFinancials$10.53+0.14%+0.4%+1.8%$363.1M
44SOULSoulpower AcquisitionFinancials$10.48+0.09%+0.3%+2.2%$355.8M
45BENJHorizon Landmark ETFFund$53.270.00%+0.3%+1.9%$354.2M
46TBTProShares Trust UltraShort Lehman 20+ Year TreasuryFund$41.53+1.52%+10.9%+15.3%$341.7M
47OBAOxley Bridge Acquisition LimitedFinancials$10.340.00%+0.3%+2.1%$327.0M
48KOYNCSLM Digital Asset Acquisition Corp IIIFinancials$10.25+0.15%+0.1%+2.1%$323.3M
49JACSJackson Acquisition Company IIFinancials$10.830.00%+0.9%+2.3%$320.5M
50OTGAOTG Acquisition Corp. IFinancials$10.260.00%+0.3%+2.1%$302.9M

Method & sources

Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology

Informational screen, not a recommendation.